Andrea Ladányi
Center of Surgical and Molecular Tumor Pathology
National Institute of Oncology
7-9. Ráth György u.
Budapest 1122
Hungary
Name/email consistency: high
- Prognostic impact of B-cell density in cutaneous melanoma. Ladányi, A., Kiss, J., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejös, Z., Gaudi, I., Dobos, J., Tímár, J. Cancer Immunol. Immunother. (2011)
- FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Ladányi, A., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejos, Z., Gaudi, I., Tímár, J. Pathol. Oncol. Res. (2010)
- Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Ladányi, A., Kiss, J., Somlai, B., Gilde, K., Fejos, Z., Mohos, A., Gaudi, I., Tímár, J. Cancer Immunol. Immunother. (2007)
- T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Ladányi, A., Somlai, B., Gilde, K., Fejös, Z., Gaudi, I., Tímár, J. Clin. Cancer Res. (2004)









